The headline numbers for Penumbra (PEN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...

Explore Penumbra's Q2 2025 earnings highlights, featuring 13.4% growth, U.S. thrombectomy success, RUBY XL launch insights, and updated revenue guidance.

The interventional radiology market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the ...